These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 27297481

  • 1. Multicenter Study of the Emergence and Genetic Characteristics of Pyrazinamide-Resistant Tuberculosis in China.
    Li D, Hu Y, Werngren J, Mansjö M, Zheng X, Drobniewski F, Hoffner S, Xu B.
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5159-66. PubMed ID: 27297481
    [Abstract] [Full Text] [Related]

  • 2. Genotypic characterization of pyrazinamide resistance in Mycobacterium tuberculosis isolated from Lusaka, Zambia.
    Bwalya P, Yamaguchi T, Mulundu G, Nakajima C, Mbulo G, Solo ES, Fukushima Y, Kasakwa K, Suzuki Y.
    Tuberculosis (Edinb); 2018 Mar; 109():117-122. PubMed ID: 29559115
    [Abstract] [Full Text] [Related]

  • 3. Resistance to pyrazinamide in Russian Mycobacterium tuberculosis isolates: pncA sequencing versus Bactec MGIT 960.
    Maslov DA, Zaĭchikova MV, Chernousova LN, Shur KV, Bekker OB, Smirnova TG, Larionova EE, Andreevskaya SN, Zhang Y, Danilenko VN.
    Tuberculosis (Edinb); 2015 Sep; 95(5):608-12. PubMed ID: 26071666
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China.
    Pang Y, Zhu D, Zheng H, Shen J, Hu Y, Liu J, Zhao Y.
    BMC Infect Dis; 2017 Nov 06; 17(1):711. PubMed ID: 29110640
    [Abstract] [Full Text] [Related]

  • 6. Phenotypic and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Ningbo, China.
    Che Y, Bo D, Lin X, Chen T, He T, Lin Y.
    BMC Infect Dis; 2021 Jun 25; 21(1):605. PubMed ID: 34171989
    [Abstract] [Full Text] [Related]

  • 7. Prevalence and transmission of pyrazinamide resistant Mycobacterium tuberculosis in China.
    Xu P, Wu J, Yang C, Luo T, Shen X, Zhang Y, Nsofor CA, Zhu G, Gicquel B, Gao Q.
    Tuberculosis (Edinb); 2016 May 25; 98():56-61. PubMed ID: 27156619
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. High prevalence of phenotypic pyrazinamide resistance and its association with pncA gene mutations in Mycobacterium tuberculosis isolates from Uganda.
    Naluyange R, Mboowa G, Komakech K, Semugenze D, Kateete DP, Ssengooba W.
    PLoS One; 2020 May 25; 15(5):e0232543. PubMed ID: 32413052
    [Abstract] [Full Text] [Related]

  • 13. Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis clinical isolates in Hangzhou, China.
    Liu W, Chen J, Shen Y, Jin J, Wu J, Sun F, Wu Y, Xie L, Zhang Y, Zhang W.
    Clin Microbiol Infect; 2018 Sep 25; 24(9):1016.e1-1016.e5. PubMed ID: 29288021
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Non-pncA Gene-Mutated but Pyrazinamide-Resistant Mycobacterium tuberculosis: Why Is That?
    Werngren J, Alm E, Mansjö M.
    J Clin Microbiol; 2017 Jun 25; 55(6):1920-1927. PubMed ID: 28404681
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Half of rifampicin-resistant Mycobacterium tuberculosis complex isolated from tuberculosis patients in Sub-Saharan Africa have concomitant resistance to pyrazinamide.
    Ngabonziza JCS, Diallo AB, Tagliani E, Diarra B, Kadanga AE, Togo ACG, Thiam A, de Rijk WB, Alagna R, Houeto S, Ba F, Dagnra AY, Ivan E, Affolabi D, Schwoebel V, Trebucq A, de Jong BC, Rigouts L, Daneau G, “Union short MDR-TB regimen study group”.
    PLoS One; 2017 Jun 25; 12(10):e0187211. PubMed ID: 29088294
    [Abstract] [Full Text] [Related]

  • 19. Pyrazinamide resistance among multidrug-resistant tuberculosis clinical isolates in a national referral center of China and its correlations with pncA, rpsA, and panD gene mutations.
    Gu Y, Yu X, Jiang G, Wang X, Ma Y, Li Y, Huang H.
    Diagn Microbiol Infect Dis; 2016 Mar 25; 84(3):207-11. PubMed ID: 26775806
    [Abstract] [Full Text] [Related]

  • 20. Pyrazinamide resistance and pncA mutations in drug resistant Mycobacterium tuberculosis clinical isolates from Myanmar.
    Ei PW, Mon AS, Htwe MM, Win SM, Aye KT, San LL, Zaw NN, Nyunt WW, Myint Z, Lee JS, Aung WW.
    Tuberculosis (Edinb); 2020 Dec 25; 125():102013. PubMed ID: 33142220
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.